Tarak Amin, DPM
Foot & Ankle Surgery · Marietta, GANPI 1376031526
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 40.7% of the total. Reporting peaked in 2022 at $4,434 and has fallen 95.5% since, to $199 in 2025.
Across 57 payments — averaging $109.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Stryker$894
- Medline Industries LP$891
- Treace Medical Concepts, Inc.$584
- Peerless Surgical Inc.$388
- Zimmer Biomet$180
- plus $778 from 11 others
What the payments were for
- Travel & lodging$1,20919%
- Food & beverage$2,64442%
- Education$2,40038%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $2,548 |
| Stryker | 15 | $894 |
| Medline Industries LP | 7 | $891 |
| Treace Medical Concepts, Inc. | 4 | $584 |
| Peerless Surgical Inc. | 4 | $388 |
| Zimmer Biomet | 2 | $180 |
| Nevro Corp. | 3 | $175 |
| Amgen | 1 | $124 |
| Paragon 28, Inc. | 1 | $120 |
| Averitas Pharma Inc. | 3 | $68 |
| Medical Device Business Services, Inc. | 1 | $68 |
| Kerecis Limited | 1 | $66 |
| Paratek Pharmaceuticals, Inc. | 2 | $49 |
| Mimedx Group, Inc. | 1 | $49 |
| Relja Innovations Inc | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $17 |
| DJO, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MEDLINE UNITE$3,096
- Lapiplasty System$425
- VARIAX$160
- PROPHECY$159
- INFINITY$156
- Trabecular Metal (TM)$133
- PENNSAID$124
- Product Portfolio$120
How this compares
$6,263 in reported general payments places this provider in the 75th percentile of 239 foot & ankle surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 25 | $874 |
| Ciclopirox | 25 | $563 |
| Cephalexin | 93 | $363 |
| Methylprednisolone | 35 | $206 |
| Clindamycin Hcl | 32 | $204 |
| Meloxicam | 74 | $199 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $165 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $75 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Marietta
- John MartucciMarietta$27K
- Michael HullMarietta$12K
- Sequioa DucasseMarietta$8K
- Robert WeinsteinFayetteville$394K
- Jason BariteauAtlanta$199K
- Scott RomanPeachtree City$118K
- Jeffrey FlashForest Park$114K
- Mickey StappThomson$110K
- David MurphyWaycross$55K
- Rishin KadakiaAtlanta$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.